Showing results (91-100 of 153) with videos related to
Sort By:
Pageof 16
Case Reports in Gastroenterology|July 13, 2016
Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous FistulaYuki Haga, Shin Yasui, Tatsuo Kanda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 31, 2023
Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in JapanTatsuo Kanda, Reina Sasaki-Tanaka, Koji Ishii, et al.International Journal of Medical Sciences|January 5, 2013
Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapyTatsuo Kanda, Shingo Nakamoto, Takayoshi Nishino, et al.International Journal of Medical Sciences|November 7, 2019
Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virusNan Nwe Win, Tatsuo Kanda, Masahiro Ogawa, et al.International Journal of Molecular Sciences|July 27, 2022
The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma CellsHiroaki Kanzaki, Tetsuhiro Chiba, Tatsuya Kaneko, et al.Oncotarget|February 14, 2018
Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literatureYuki Haga, Tatsuo Kanda, Shin Yasui, et al.JHEP Reports : Innovation in Hepatology|October 1, 2025
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinomaKeisuke Koroki, Sadahisa Ogasawara, Sae Yumita, et al.Cancer Medicine|February 27, 2025
Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination ImmunotherapyChihiro Miwa, Sadahisa Ogasawara, Takuya Yonemoto, et al.Plos One|January 27, 2022
Impact of acute decompensation on the prognosis of patients with hepatocellular carcinomaTakayuki Kondo, Keisuke Koroki, Hiroaki Kanzaki, et al.American Journal of Physiology. Cell Physiology|September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesisJunjie Ao, Na Qiang, Hiroaki Kanzaki, et al.Pageof 16